TVP-1012 1mg
TVP-1012/OCT-002
Phase 3 small_molecule completed
Quick answer
TVP-1012 1mg for Parkinson's Disease is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Parkinson's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed